Endogenic PharmacologyThe Canonical Reference
Delivery Platforms · Advanced and Nanocarrier Delivery

Smart Connected Delivery Systems

Sensor-equipped delivery systems with app-paired tracking, closed-loop biomarker-driven dose adjustment, and connected clinical-monitoring infrastructure.

The Atumnus Smartgenix™ Platform

Definition

Sensor-equipped delivery systems with app-paired tracking, closed-loop biomarker-driven dose adjustment, and connected clinical-monitoring infrastructure.

Full mechanistic definition forthcoming.


Pharmaceutical History

A documented format in pharmaceutical practice.

Historical timeline of the delivery format in the pharmaceutical literature — first characterization, commercial precedents, decades of regulatory-approved use — forthcoming.


Mechanism and Pharmacokinetics

How the format delivers.

Absorption pathway, bioavailability characteristics, first-pass metabolism considerations, onset and duration profiles — forthcoming.


Applicable Compounds

Bioregulators formulated for this platform.

Bioregulator compounds delivered through programmable, sensor-equipped, and biomarker-responsive delivery hardware.

See the full bioregulator class and the per-compound published literature for compound-specific research references.


Regulatory Pathway

Classification and oversight.

510(k) device classification, NDA pathways, and FDA digital-therapeutic regulatory frameworks.

Detailed regulatory analysis — agency-specific requirements, classification thresholds, and pathway-specific labeling considerations — forthcoming.


Peer-Reviewed Foundation

The format in the scientific literature.

PubMed-indexed peer-reviewed references establishing the format as legitimate pharmaceutical science — forthcoming.


The Atumnus Implementation

The Atumnus Smartgenix™ platform.

The Smartgenix™ platform is the Atumnus patent-pending embodiment of Smart Connected Delivery Systems. It is licensed to operating affiliates for commercial development across the Opticeutical and Endoceutical tiers, and is one of the branded delivery technologies that anchors the Atumnus intellectual-property estate.

The Smartgenix™ trademark and associated patent-pending technology are held by Atumnus LLC, the founding entity of endogenic pharmacology. See affiliated entities for institutional structure.


Related Platforms

Adjacent delivery formats.

Within the same cluster (Advanced and Nanocarrier Delivery), see the full set of delivery platforms in this category.

← Back to all delivery platforms